IgA Nephropathy Patients on Trutakna Kept Kidney Function Nearly Steady for Two Years While Placebo Group Declined

Two-year ORIGIN 3 data show Trutakna held kidney function nearly steady in IgA nephropathy. What it means for patients, coverage, and approval.

Have A Referral?